Related content

Restricted upper extremity range of motion in mucopolysaccharidosis type I: no response to one year of enzyme replacement therapy

By Cox-Brinkman J.   Smeulders M.   Hollak C.   Wijburg F.  

Journal of Inherited Metabolic Disease, Vol. 30, Iss. 1, 2007-02 ,pp. : 47-50

Springer Publishing Company

Access to resources Recommend Favorite

Postmortem studies on a patient with mucopolysaccharidosis type I: Histopathological findings after one year of enzyme replacement therapy

By Yano S.   Moseley K.   Pavlova Z.  

Journal of Inherited Metabolic Disease, Vol. 32, Iss. 1, 2009-12 ,pp. : 53-57

Springer Publishing Company

Access to resources Recommend Favorite

Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome

By Thomas J.   Jacobs S.   Kierstein J.   Hove J.  

Journal of Inherited Metabolic Disease, Vol. 29, Iss. 6, 2006-12 ,pp. : 762-762

Springer Publishing Company

Access to resources Recommend Favorite

The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome)

By Miebach Elke   Church Heather   Cooper Alan   Mercer Jean   Tylee Karen   Wynn Robert   Wraith J.  

Journal of Inherited Metabolic Disease, Vol. 34, Iss. 3, 2011-06 ,pp. : 755-761

Springer Publishing Company

Access to resources Recommend Favorite

Relief of gastrointestinal symptoms under enzyme replacement therapy in patients with Fabry disease

By Dehout F.   Roland D.   de Granseigne S.   Guillaume B.   Van Maldergem L.  

Journal of Inherited Metabolic Disease, Vol. 27, Iss. 4, 2004-07 ,pp. : 499-505

Springer Publishing Company

Access to resources Recommend Favorite